Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Total Liabilities (2019 - 2025)

BioScience Health Innovations (BHIC) has disclosed Total Liabilities for 7 consecutive years, with $229851.0 as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 496.27% to $229851.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $229851.0 through Dec 2025, up 496.27% year-over-year, with the annual reading at $229851.0 for FY2025, 496.27% up from the prior year.
  • Total Liabilities for Q4 2025 was $229851.0 at BioScience Health Innovations, down from $356140.0 in the prior quarter.
  • The five-year high for Total Liabilities was $356140.0 in Q3 2025, with the low at $1860.0 in Q3 2022.
  • Average Total Liabilities over 5 years is $86057.6, with a median of $39243.5 recorded in 2024.
  • The sharpest move saw Total Liabilities crashed 90.26% in 2022, then soared 1277.58% in 2025.
  • Over 5 years, Total Liabilities stood at $23015.0 in 2021, then crashed by 87.54% to $2867.0 in 2022, then skyrocketed by 3393.13% to $100148.0 in 2023, then crashed by 61.51% to $38548.0 in 2024, then soared by 496.27% to $229851.0 in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $229851.0, $356140.0, and $337632.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.